SCHEMBL8718547

SCHEMBL8718547

O=Cc1ccccc1/C=C/c1nc2ccccc2o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.54
HDAC4 P56524 1/20 0.54
HDAC1 Q13547 1/20 0.54
HDAC7 Q8WUI4 1/20 0.54
HDAC2 Q92769 1/20 0.54
HDAC10 Q969S8 1/20 0.54
HDAC11 Q96DB2 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54
HDAC9 Q9UKV0 1/20 0.54
HDAC5 Q9UQL6 1/20 0.54
SNCA P37840 1/20 0.50
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
NPC1 O15118 5/20 0.49
RAB9A P51151 5/20 0.49
APP P05067 1/20 0.49
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8718548 1.00 HDAC3 (0.54) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6421503 0.84 SNCA (0.64) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6421501 0.84 SNCA (0.64) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL223564 0.81 HDAC3 (0.56) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6607140 0.81 MEN1 (0.63) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6607138 0.81 MEN1 (0.63) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8593114 0.78 SNCA (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL7472176 0.78 SNCA (0.62) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL7472170 0.78 SNCA (0.62) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL9000333 0.78 SNCA (0.57) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840721-A INCREASE SENSITIVITY OF MULTIDRUG RESISTANT TUMOR CELLS TO ANTICANCER AGENTS ONTOGEN CORPORATION (US) 1998-11-24 US disclosed